event-trade登录编辑
ReutersCodex · 实盘不做把握 6/10
北京时间·源无时间·以抓取为准·⟳ 抓取 15:47:22·⚡ 决策 07-23 15:51:40 +4m18s·96.2 天前

Galderma上半年销售增长24.6%并上调全年净销售增长指引至19%-21%

Galderma上半年销售额31.3亿美元,同比增长24.6%,并将全年净销售增长指引由17%-20%上调至19%-21%。

📄 原文Reuters↗ 原文
Swiss skincare firm Galderma (GALD.S) on Thursday reported a ​24.6% jump in sales in ‌the first half of the year and nu…
不做 Galderma(GALD.CH)
财报和指引上调方向偏正面,但缺少相对一致预期、利润超预期和实时价格反应,无法确认剩余edge,不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

🔎 新鲜度:最早出现 2026-07-23 · 扩散 high · price-in 风险 medium ↗

关键理由

  • Galderma上半年销售额31.3亿美元,同比增长24.6%,并将全年净销售增长指引由17%-20%上调至19%-21%。
  • 增长来自美国和国际市场以及全部品类的双位数增长,方向明确偏正面。
  • 但这是欧洲本地交易时段内的财报/指引更新,正文未给出相对市场一致预期、利润率或现金流超预期幅度。

主要风险

  • 公司同时提示美国关税和下半年消费需求恶化风险,且缺少当前价格反应和一致预期差,难以判断还有未反应edge。

原文全文

展开原文 · 852 字
Swiss skincare firm Galderma (GALD.S) on Thursday reported a ​24.6% jump in sales in ‌the first half of the year and nudged up its full-year net ​sales growth guidance, citing ​double-digit growth in international markets and ⁠the U.S.

First-half sales rose to $3.13 ​billion, and the company now ​expects net sales to grow 19-21% this year from a previous target of ​17-20%.

The Zug-based company said it ​had registered double-digit growth in both international ‌markets ⁠and the United States as well as in all product categories, chiefly driven by volume ​and complemented ​by favourable ⁠mix.

Galderma said its full-year guidance factors in manageable ​exposure to announced U.S. ​tariffs, ⁠along with the ability to absorb potential consumer demand deterioration in ⁠the ​second half, given ​a volatile political and macroeconomic environment.

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。